Privia Health Group, Inc.

Privia Health Group, Inc.PRVAEarnings & Financial Report

Nasdaq · Health Care · Services-Health Services

Privia Health Group, Inc. is a U.S.-headquartered healthcare technology and services firm supporting independent practices, health systems, and payers delivering value-based care. It offers population health tools, patient engagement platforms, care coordination support, and workflow solutions to boost patient outcomes and cut operational costs for U.S. healthcare stakeholders.

PRVA Q1 FY2026 Key Financial Metrics

Revenue

$603.8M

Gross Profit

$125.6M

Operating Profit

$7.4M

Net Profit

$3.7M

Gross Margin

20.8%

Operating Margin

1.2%

Net Margin

0.6%

YoY Growth

25.8%

EPS

$0.02

Privia Health Group, Inc. Q1 FY2026 Financial Summary

Privia Health Group, Inc. reported revenue of $603.8M (up 25.8% YoY) for Q1 FY2026, with a net profit of $3.7M (down 27.4% YoY) (0.6% margin). Cost of goods sold was $478.2M, operating expenses totaled $118.2M.

Key Financial Metrics

Total Revenue$603.8M
Net Profit$3.7M
Gross Margin20.8%
Operating Margin1.2%
Report PeriodQ1 FY2026

Revenue Breakdown

Privia Health Group, Inc. Q1 FY2026 revenue of $603.8M breaks down across 6 segments, led by FFS-patient care at $391.1M (64.8% of total).

SegmentRevenue% of Total
FFS-patient care$391.1M64.8%
Capitated revenue$86.1M14.3%
Other$75.0M12.4%
FFS-administrative services$31.4M5.2%
Care management fees (PMPM)$17.9M3.0%
Other revenue$2.3M0.4%

Privia Health Group, Inc. Annual Revenue by Year

Privia Health Group, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.1B).

YearAnnual Revenue
2025$2.1Bvs 2024
2024$1.7Bvs 2023
2023$1.7Bvs 2022
2022$1.4B

Privia Health Group, Inc. Quarterly Revenue & Net Profit History

Privia Health Group, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q1 FY2026$603.8M+25.8%$3.7M0.6%
Q4 FY2025$541.2M+17.4%$9.2M1.7%
Q3 FY2025$580.4M+32.5%$6.9M1.2%
Q2 FY2025$521.2M+23.4%$2.7M0.5%
Q1 FY2025$480.1M+15.6%$4.2M0.9%
Q4 FY2024$460.9M+4.6%$4.4M1.0%
Q3 FY2024$437.9M+4.9%$3.5M0.8%
Q2 FY2024$422.3M+2.2%$3.5M0.8%

Income Statement

Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Revenue$422.3M$437.9M$460.9M$480.1M$521.2M$580.4M$541.2M$603.8M
YoY Growth2.2%4.9%4.6%15.6%23.4%32.5%17.4%25.8%

Balance Sheet

Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Assets$1.08B$1.15B$1.14B$1.18B$1.27B$1.35B$1.37B$1.42B
Liabilities$434.0M$483.4M$452.3M$474.0M$539.0M$588.2M$578.4M$612.0M
Equity$595.4M$614.9M$635.2M$659.4M$682.9M$709.1M$737.2M$805.9M

Cash Flow

Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Operating CF$34.5M$33.2M$74.8M$-24.1M$8.0M$52.0M$127.5M$-49.5M